FDA Outlines Immediate National Strategy to Further Increase the Resiliency of the U.S. Infant Formula Market
http://www.fda.gov/news-events/press-announcements/fda-outlines-immediate-national-strategy-further-increase-resiliency-us-infant-formula-market

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jarmans-midwest-cleaning-systems-inc-issues-voluntary-nationwide-recall-alcohol-antiseptic-80

FDA Roundup: March 24, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-march-24-2023

FDA Works to Further Improve Nutrition, Reduce Diet-Related Chronic Disease with Dietary Guidance Statements on Food Labels
http://www.fda.gov/news-events/press-announcements/fda-works-further-improve-nutrition-reduce-diet-related-chronic-disease-dietary-guidance-statements

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval
http://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-aimed-improving-oncology-clinical-trials-accelerated-approval

FDA Takes Additional Steps to Improve Nutrition, Reduce Disease with Expanded Use of Salt Substitutes to Help Lower Sodium Intake
http://www.fda.gov/news-events/press-announcements/fda-takes-additional-steps-improve-nutrition-reduce-disease-expanded-use-salt-substitutes-help-lower

http://www.fda.gov/medical-devices/safety-communications/risks-exactech-joint-replacement-devices-defective-packaging-fda-safety-communication

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ascend-laboratories-llc-issues-voluntary-nationwide-recall-dabigatran-etexilate-capsules-usp-75-mg

http://www.fda.gov/medical-devices/safety-communications/update-reports-squamous-cell-carcinoma-scc-capsule-around-breast-implants-fda-safety-communication

FDA Roundup: March 21, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-march-21-2023